SUMO

亜型選択性的な製品

SENP SENP2

SUMO製品

All (7)
SUMO阻害剤 (6)
新製品

製品コード	製品名称	製品説明	文献中Selleckの製品使用例	お客様のフィードバック
S8696	2-D08	2-D08 (2',3',4'-trihydroxy flavone) is a cell permeable, mechanistically unique inhibitor of protein sumoylation.	Commun Biol, 2025, 8(1):1118 Int Immunopharmacol, 2025, 149:114187 Nat Commun, 2024, 15(1):9195
S8829	Subasumstat (TAK-981)	Subasumstat (TAK-981) is a novel, selective inhibitor of the SUMOylation enzymatic cascade with potential immune-activating and antineoplastic activities.	Oncogene, 2025, none Commun Biol, 2025, 8(1):1005 Int Immunopharmacol, 2025, 149:114187
S9432	Ginkgolic Acid	Ginkgolic acid, toxic phenolic compounds present in the fruits and leaves of Ginkgo biloba L., is a potent sumoylation inhibitor also reported to inhibit histone acetylation transferase (HAT).	Microbiologyopen, 2025, 14(4):e70038 Pharmaceutics, 2024, 16(5)638 CNS Neurosci Ther, 2022, 10.1111/cns.13871
S9159	momordin-Ic	Momordin Ic, a natural triterpenoid saponin, is a novel SENP1 (SUMO-specific protease 1) inhibitor that inhibited proliferation of prostate cancer cells in vitro and in vivo.	Int J Mol Sci, 2022, 23(15)8282
F1164	SENP1 Antibody [L6L19]	SENP1 Rabbit mAb detects endogenous levels of total SENP1 protein.
S4922	NSC 632839	NSC 632839 is not only a DUB inhibitor, but also a deSUMOylase inhibitor, it inhibits USP2, USP7, and SENP2 with EC50 of 45 μM, 37 μM, and 9.8 μM, respectively.
S9445	Ginkgolic Acid (C13:0)	Ginkgolic Acid (C13:0) is a natural anticariogenic agent in Ginkgo biloba L. that exhibits antimicrobial activity against S. mutans and suppresses the specific virulence factors associated with its cariogenicity. Ginkgolic acid is a potent sumoylation inhibitor and reported to inhibit histone acetylation transferase (HAT).
S8696	2-D08	2-D08 (2',3',4'-trihydroxy flavone) is a cell permeable, mechanistically unique inhibitor of protein sumoylation.	Commun Biol, 2025, 8(1):1118 Int Immunopharmacol, 2025, 149:114187 Nat Commun, 2024, 15(1):9195
S8829	Subasumstat (TAK-981)	Subasumstat (TAK-981) is a novel, selective inhibitor of the SUMOylation enzymatic cascade with potential immune-activating and antineoplastic activities.	Oncogene, 2025, none Commun Biol, 2025, 8(1):1005 Int Immunopharmacol, 2025, 149:114187
S9432	Ginkgolic Acid	Ginkgolic acid, toxic phenolic compounds present in the fruits and leaves of Ginkgo biloba L., is a potent sumoylation inhibitor also reported to inhibit histone acetylation transferase (HAT).	Microbiologyopen, 2025, 14(4):e70038 Pharmaceutics, 2024, 16(5)638 CNS Neurosci Ther, 2022, 10.1111/cns.13871
S9159	momordin-Ic	Momordin Ic, a natural triterpenoid saponin, is a novel SENP1 (SUMO-specific protease 1) inhibitor that inhibited proliferation of prostate cancer cells in vitro and in vivo.	Int J Mol Sci, 2022, 23(15)8282
S4922	NSC 632839	NSC 632839 is not only a DUB inhibitor, but also a deSUMOylase inhibitor, it inhibits USP2, USP7, and SENP2 with EC50 of 45 μM, 37 μM, and 9.8 μM, respectively.
S9445	Ginkgolic Acid (C13:0)	Ginkgolic Acid (C13:0) is a natural anticariogenic agent in Ginkgo biloba L. that exhibits antimicrobial activity against S. mutans and suppresses the specific virulence factors associated with its cariogenicity. Ginkgolic acid is a potent sumoylation inhibitor and reported to inhibit histone acetylation transferase (HAT).